“十二五”医药业发展走势:结构调整产业升级成主旋律

Development Tendency of Pharmaceutical industry in the Twelfth Five-Year Plan Time Period:Structural Adjustment and Industry’s Upgrade Become the Theme

未来3～5年,伴随医疗资源下沉、"全民医保"提前实现、基本药物制度自2011年起进入实质性实施阶段,必将撬动潜力巨大的基层消费市场,行业有望继续保持20%～25%快速增长。在目前药价趋降的形势下,创新类产品无疑会获得价格和审批等诸多优惠,这对具有创新能力尤其是具备研制国际前沿一类新药的企业将会带来腾飞的机会,医药行业未来十年将快速发展,可以称为黄金十年。

In the coming three to five years, with the sinking of the medical resource, to realize the ＂universal coverage＂ in advance, and theessential drug system entering implementation phase from 201 I, it must motivate the potentially huge grassroots consumer market, the pharmaceutical industry will keep 20%--30% rapid increase. With the medicine prices dropping, the innovative products will obtain some privilege undoubtedly, such as preferential price and approval, etc. This will bring a soaring opportunity to the enterprises which have creative ability, especially to the enterprises which have the ability of developing international frontiers of first class medicines. Pharmaceutical industry will have a fast development in the next decade, which could be called ＂Golden Decade＂.